# Filing Detail

Form DRS - Draft Registration Statement:
SEC Accession No. 0001193125-26-081986
Filing Date
2026-02-27
Accepted
2026-02-27 14:14:21
Documents
26

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | filename1.htm | DRS | 2159564
2 |  | filename2.htm | EX-10.4 | 134344
3 |  | filename3.htm | EX-10.5 | 204458
4 | GRAPHIC | g50309g00a01.jpg | GRAPHIC | 184466
5 | GRAPHIC | g50309g01a30.jpg | GRAPHIC | 136781
6 | GRAPHIC | g50309g01e02.jpg | GRAPHIC | 142349
7 | GRAPHIC | g50309g03m01.jpg | GRAPHIC | 233664
8 | GRAPHIC | g50309g04m02.jpg | GRAPHIC | 115401
9 | GRAPHIC | g50309g05m03.jpg | GRAPHIC | 111066
10 | GRAPHIC | g50309g06m01.jpg | GRAPHIC | 123887
11 | GRAPHIC | g50309g06m02.jpg | GRAPHIC | 121678
12 | GRAPHIC | g50309g07m01.jpg | GRAPHIC | 100887
13 | GRAPHIC | g50309g07m02.jpg | GRAPHIC | 127566
14 | GRAPHIC | g50309g08m03.jpg | GRAPHIC | 130832
15 | GRAPHIC | g50309g09m01.jpg | GRAPHIC | 186558
16 | GRAPHIC | g50309g10m01.jpg | GRAPHIC | 308560
17 | GRAPHIC | g50309g11m02.jpg | GRAPHIC | 127403
18 | GRAPHIC | g50309g12m03.jpg | GRAPHIC | 168561
19 | GRAPHIC | g50309g13m04.jpg | GRAPHIC | 61928
20 | GRAPHIC | g50309g15m06.jpg | GRAPHIC | 144916
21 | GRAPHIC | g50309g16m01.jpg | GRAPHIC | 107046
22 | GRAPHIC | g50309g16m02.jpg | GRAPHIC | 76410
23 | GRAPHIC | g50309g17m01.jpg | GRAPHIC | 131701
24 | GRAPHIC | g50309g17m02.jpg | GRAPHIC | 139292
25 | GRAPHIC | g50309g62g77.jpg | GRAPHIC | 55595
26 | GRAPHIC | g50309g99a30.jpg | GRAPHIC | 133309
| Complete submission text file | 0001193125-26-081986.txt |  | 6635898

Mailing Address 101 MAIN STREET SUITE 1220 CAMBRIDGE MA 02142
Business Address 101 MAIN STREET SUITE 1220 CAMBRIDGE MA 02142 45 2138 7627
Hemab Therapeutics Holdings, Inc. (Filer) CIK: 0002114044 (see all company filings)

EIN.: 414241952 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DRS | Act: 33 | File No.: 377-09105 | Film No.: 26697551
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)